We found that in mice engrafted with AML cells, treatment with CD70-CAR-T cells resulted in a significant reduction in tumor burden and prolonged survival (Figures 4B–D); however, CD70-CAR-T cells became undetectable on day 18 post-infusion and eventually, all mice died from leukemia progression. This evidence concerns the gene CD70 and neoplasm.